Gain Therapeutics, Inc.
USD1.97
-0.01 (-0.51%)
CEO
Gene Mack
IPO Date
2021-03-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.95
Prev. Close
$1.98
Day Low
$1.93
Day High
$2.02
52W Low
$1.41
52W High
$4.34
Market Cap
$0.08B
Volume
1.12M
| -2.4 |
| 31 Dec 2023 | FY | 100.0% | -40354.3% | -177.0% | -119.7% | 0.08 | 3.59 | -1.9 |
| 31 Dec 2022 | FY | 100.0% | -12555.1% | -93.2% | -73.0% | 0.07 | 5.11 | -2.1 |
| 31 Dec 2021 | FY | 100.0% | -8418.9% | -39.9% | -35.6% | 0.05 | 14.78 | -4.0 |
| 31 Dec 2020 | FY | 100.0% | -12387.7% | -57.7% | -37.3% | 0.20 | 4.25 | -37.2 |
| 31 Dec 2019 | FY | 100.0% | -5310.9% | 487.6% | -332.2% | -0.45 | 0.45 | -42.8 |
| 31 Dec 2018 | FY | 100.0% | -5364.4% | 116.3% | -136.2% | -1.37 | 0.93 | -59.4 |
| -5.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -89.4% | -48.2% | 0.10 | 2.52 | -2.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -157.2% | -59.1% | 0.18 | 1.79 | -2.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -78.4% | -39.0% | 0.10 | 2.22 | -3.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -51.3% | -31.1% | 0.09 | 2.97 | -3.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -50.3% | -31.2% | 0.09 | 2.99 | -2.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -69.1% | -42.4% | 0.07 | 2.84 | -0.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -46.4% | -27.5% | 0.10 | 2.77 | -4.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -37.6% | -25.4% | 0.08 | 3.59 | -2.8 |